NyfikenGrau
Medlem
Som sagt, skrev just efter ankomst.
Kan detta betyda att USA öppnar upp?
- Thread starter Bridgeman
- Startdatum
- Status
Som sagt, skrev just efter ankomst.
palmen
Moderator
Din gissning är lika god som någon annans, men jag antar att det är innan halva november passerat, för då skulle det inte vara i början på november. Min personliga förhoppning är att det verkställs den första veckan i november.Någon som törs gissa på när "early November" är? 1:a Nov? 6:e? 14:e??
Direktöversatt blir det ju "tidiga november/tidigt i november", men min fråga är mer om det i Amerika räknas strikt som 1:a nov, eller mer vagt som, nån gång första halvan av nov.
"Frågar för en vän" som har resa bokad den 6:e
Bankiren
Medlem
Bästa energigivartråden på länge! Förstår att ingen konkret information kommer komma hit på ett tag, men det är så roligt att se allas förväntan. Vi har en befintlig resa bokad till oktober, men det känns helt okej att boka om nät man faktiskt har något att tro på, på riktigt denna gång.
Bankiren
Medlem
Bästa energigivartråden på länge! Förstår att ingen konkret information kommer komma hit på ett tag, men det är så roligt att se allas förväntan. Vi har en befintlig resa bokad till oktober, men det känns helt okej att boka om nät man faktiskt har något att tro på, på riktigt denna gång.
Jag är lite försiktigt optimistisk. Men har allt bokat för en resa i december (kryssning med Norwegian Joy), så man hoppas ju att allt går vägen.
Mattias Holmén
Medlem
Jag tror mer det handlar om hur många doser tillverkaren har angett i sin behandlingsmetod. I dagsläget är det 2 för de flesta vaccin. Att vissa länder ger 3 sprutor har inte så mycket att göra med om man är fullvaccinerad eller inte.
Edit: med betoning på tror.
Last edited:
Allt är ju föränderligt men så här definierar CDC "Fully vaccinated":
In general, people are considered fully vaccinated:
Så det indikerar ju precis som Mattias skriver ovan att förändras behandlingsmetoden så förändras definitionen.
In general, people are considered fully vaccinated:
- 2 weeks after their second dose in a 2-dose series, such as the Pfizer or Moderna vaccines, or
- 2 weeks after a single-dose vaccine, such as Johnson & Johnson’s Janssen vaccine
Så det indikerar ju precis som Mattias skriver ovan att förändras behandlingsmetoden så förändras definitionen.
Homer
Medlem
Ang. 3:e spruta, detta är vad som sades av pressekreteraren
Q And just a quick one on boosters: Why did the President say in August, “Just remember, as a simple rule: Eight months after your second shot, get a booster shot” if there is not enough data to support that for the general population?
MS. PSAKI: Well, what the President [Surgeon General] also said is that, “I want to be very clear, the plan is pending the FDA conducting in an independent evaluation of the safety and effectiveness of a third dose of the Pfizer and Moderna vaccines and the CDC’s Advisory Committee.”
We are right now in the week of September 20th. The advisory committee is meeting on Thursday. We’ve seen some recommendations that we felt was a step forward in providing more protection to people across the country. And we’ll wait for that process to play out.
Our objective and our role is to ensure we have the capacity, the number of shots to provide them to the American people.
Q Sixteen out of eighteen FDA advisors say there is not the science. The President talks about “following the science.” Is this a case of him getting ahead on the science?
MS. PSAKI: Well, first of all, I think what you heard Dr. Collins and Dr. Fauci convey yesterday is that this is going to be an ongoing process.
I would remind you that the percentage of individuals, at this point, who would be eligible to get a booster are largely people over 65, because those are people who would have had the second dose six months ago.
If we’re looking at when we’re going to have available data — that’s what the CDC and the FDA looks at — they need enough data to make assessments. No one is suggesting that there will never be boosters. We are suggesting that there needs to be a process to be seen through for when boosters should be approved and when a broader swath of the population is eligible.
senare:
Q — on behalf of people who look at what happened last week and were disappointed. They may be six-plus months out from their second shot and they want a booster shot today; they don’t want to wait. Can you explain the process to those people —
MS. PSAKI: Sure.
Q — and address their concerns?
And in particular, get at the question of accountability, because it was the eight health experts who surround the President, who are best known to the country — perhaps most trusted by the country — who suggested that this would be the week. Who were these people who were deciding that it shouldn’t be this week or that shouldn’t be people under the age of 65?
MS. PSAKI: Well, even — those eight health experts who, you’re right, put out the statement in August based on data that we had — that they had available to them as health experts suggesting the waning influence — or the waning impact, I should say — the waning effectiveness of vaccines, they felt they had a responsibility to make their recommendations, their views public to the American people. That’s exactly what they did.
There’s also a process in place for a reason. And I would say — I think any of us would say — to anyone who’s frustrated or who wants to have their booster shot now: That process is in place for a reason so that you can trust what the final recommendation and the final outcome is. And it includes — obviously, last week, there was — the FDA had their own review and their own process, a formal meeting of the Advisory Committee. ACIP is meeting this week.
But this is not the last meeting. I think that’s important for people to understand, and Dr. Fauci referenced this yesterday. There will be additional data. There will be additional data from probably Moderna, from J&J, others in the coming weeks. There’ll be more data for people who are younger than 65. They will look at all of that.
This is an ongoing process. This is not a decision that there will never be boosters for others. This is the first step in a process — a positive one, in our view — about protecting more people.
And — but it is also important to keep the FDA as the gold standard and ensure that process proceeds so people can trust their recommendations.
Q — have one foreign policy question for you. Now that the FDA’s vaccine advisors have recommended boosters for people 65 and up, how soon do you expect President Biden to get his booster shot? And will he do so on camera?
MS. PSAKI: He will do so, and he will do so on camera. I don’t have a date for you exactly.
Press Briefing by Press Secretary Jen Psaki, September 20, 2021 | The White House
Q And just a quick one on boosters: Why did the President say in August, “Just remember, as a simple rule: Eight months after your second shot, get a booster shot” if there is not enough data to support that for the general population?
MS. PSAKI: Well, what the President [Surgeon General] also said is that, “I want to be very clear, the plan is pending the FDA conducting in an independent evaluation of the safety and effectiveness of a third dose of the Pfizer and Moderna vaccines and the CDC’s Advisory Committee.”
We are right now in the week of September 20th. The advisory committee is meeting on Thursday. We’ve seen some recommendations that we felt was a step forward in providing more protection to people across the country. And we’ll wait for that process to play out.
Our objective and our role is to ensure we have the capacity, the number of shots to provide them to the American people.
Q Sixteen out of eighteen FDA advisors say there is not the science. The President talks about “following the science.” Is this a case of him getting ahead on the science?
MS. PSAKI: Well, first of all, I think what you heard Dr. Collins and Dr. Fauci convey yesterday is that this is going to be an ongoing process.
I would remind you that the percentage of individuals, at this point, who would be eligible to get a booster are largely people over 65, because those are people who would have had the second dose six months ago.
If we’re looking at when we’re going to have available data — that’s what the CDC and the FDA looks at — they need enough data to make assessments. No one is suggesting that there will never be boosters. We are suggesting that there needs to be a process to be seen through for when boosters should be approved and when a broader swath of the population is eligible.
senare:
Q — on behalf of people who look at what happened last week and were disappointed. They may be six-plus months out from their second shot and they want a booster shot today; they don’t want to wait. Can you explain the process to those people —
MS. PSAKI: Sure.
Q — and address their concerns?
And in particular, get at the question of accountability, because it was the eight health experts who surround the President, who are best known to the country — perhaps most trusted by the country — who suggested that this would be the week. Who were these people who were deciding that it shouldn’t be this week or that shouldn’t be people under the age of 65?
MS. PSAKI: Well, even — those eight health experts who, you’re right, put out the statement in August based on data that we had — that they had available to them as health experts suggesting the waning influence — or the waning impact, I should say — the waning effectiveness of vaccines, they felt they had a responsibility to make their recommendations, their views public to the American people. That’s exactly what they did.
There’s also a process in place for a reason. And I would say — I think any of us would say — to anyone who’s frustrated or who wants to have their booster shot now: That process is in place for a reason so that you can trust what the final recommendation and the final outcome is. And it includes — obviously, last week, there was — the FDA had their own review and their own process, a formal meeting of the Advisory Committee. ACIP is meeting this week.
But this is not the last meeting. I think that’s important for people to understand, and Dr. Fauci referenced this yesterday. There will be additional data. There will be additional data from probably Moderna, from J&J, others in the coming weeks. There’ll be more data for people who are younger than 65. They will look at all of that.
This is an ongoing process. This is not a decision that there will never be boosters for others. This is the first step in a process — a positive one, in our view — about protecting more people.
And — but it is also important to keep the FDA as the gold standard and ensure that process proceeds so people can trust their recommendations.
Q — have one foreign policy question for you. Now that the FDA’s vaccine advisors have recommended boosters for people 65 and up, how soon do you expect President Biden to get his booster shot? And will he do so on camera?
MS. PSAKI: He will do so, and he will do so on camera. I don’t have a date for you exactly.
Press Briefing by Press Secretary Jen Psaki, September 20, 2021 | The White House
pswe
Medlem
Någon som sett någonting i närtid kring hur de kommer se på Astras vaccin?
- Status